Autism social trial halted: memantine shows no promise
NCT ID NCT03553875
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study tested whether memantine, a medication for Alzheimer's, could improve social skills in youth aged 8-18 with autism or nonverbal learning disability. The trial was stopped early after enrolling only 25 participants. The main goal was to measure changes in social functioning using a clinician rating scale.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for AUTISM are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Massachusetts General Hospital
Boston, Massachusetts, 02114, United States
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Gentle massage and calming sounds: a new bedtime ritual for autistic kids?
- Can a camera catch autism signs in preemie toddlers?
- Light-Up training pods may sharpen reflexes in autistic teen athletes
- Could online coaching for parents boost autistic Children's social skills?
- Can a new curriculum help autistic adults navigate romance?
- Could a phone app help parents of kids with special needs thrive?